-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Beijing, China and Cambridge, Massachusetts, U.
Dr.
About Gaucher disease (GD)
Gaucher disease is one of the most common lysosomal storage diseases.
About Beihai Kangcheng Pharmaceutical Co.
Beihai Kangcheng Pharmaceutical Co.
Beihai Kangcheng has a comprehensive and differentiated pipeline composed of 13 pharmaceutical assets with huge market potential, targeting some of the most common rare diseases and rare tumors
These diseases include Hunter syndrome (MPS II) and other lysosomal storage diseases (LSD), complement-mediated diseases, hemophilia A, metabolic disorders, rare cholestatic liver diseases and neuromuscular diseases, and glial Blastoma (GBM)
Beihai Kangcheng strategically combines global cooperation with internal research to establish a diversified drug portfolio, while investing in the next generation of gene therapy technology for rare disease treatment
For more information about Beihai Kangcheng Pharmaceutical Co.
Source: Beihai Kangcheng